跳至主要内容
临床试验/EUCTR2006-006588-21-IT
EUCTR2006-006588-21-IT进行中(未招募)不适用

Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection - ND

AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)0 个研究点开始时间: 2007年5月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • HIV/HCV co-infection
  • Hystologic confirmation of chronic hepatitis
  • CD4 cell count > or equal to 350/mmc
  • HIV-RNA < 20,000 cp/mL
  • Absence of autoantibodies
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Allergy or intolerance to the study medication
  • previous treatment with IFN or ribavirin
  • End-stage liver disease
  • Alcohol abuse

研究者

发起方
AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)

相似试验